ENTPD1 and polycystic ovary syndrome: The genetically predicted CD39+ CD4+ %CD4+ (Treg panel) exhibited a noticeable protective effect against PCOS (IVW: OR [95%]:0.869 [0.784 to 0.963], p = 0.008).